Text Size
3490 studies found for:    "Lung Neoplasms"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Terminated Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Stage II Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Drug: paclitaxel;   Biological: bevacizumab;   Drug: carboplatin;   Other: laboratory biomarker analysis
22 Completed S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
23 Active, not recruiting Pemetrexed Disodium and Cisplatin in Treating Patients Undergoing Surgery For Stage I-III Non-Small Cell Lung Cancer
Conditions: Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: cisplatin;   Drug: pemetrexed disodium;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography;   Radiation: fludeoxyglucose F 18;   Procedure: therapeutic conventional surgery
24 Terminated Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection
Conditions: Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Procedure: therapeutic endoscopic surgery;   Other: laboratory biomarker analysis
25 Completed Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Drug: etoposide;   Drug: gefitinib;   Radiation: radiation therapy;   Other: placebo
26 Completed Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Large Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: shark cartilage extract AE-941;   Other: placebo;   Drug: cisplatin;   Drug: vinorelbine tartrate;   Drug: carboplatin;   Drug: paclitaxel;   Radiation: radiation therapy
27 Active, not recruiting MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer
Interventions: Drug: Akt inhibitor MK2206;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacological study
28 Not yet recruiting Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy
Conditions: Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer
Interventions: Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: Fourier transform ion cyclotron resonance mass spectrometry;   Other: medical chart review;   Other: laboratory biomarker analysis
29 Not yet recruiting Photodynamic Therapy During Surgery in Treating Patients With Non-Small Cell Lung Cancer That Can be Removed by Surgery
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: HPPH;   Procedure: therapeutic conventional surgery;   Other: photodynamic therapy
30 Suspended Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Conditions: Lung Cancer;   Lung Cancer Non-Small Cell Cancer (NSCLC);   Lung Cancer Small Cell Lung Cancer (SCLC);   Mesothelioma
Interventions: Procedure: Stereotactic Body Radiation Therapy (SBRT);   Drug: Iohexol;   Radiation: Computed Tomography (CT);   Device: Cyberknife;   Device: Trilogy;   Device: True Beam
31 Completed
Has Results 		Dose/ Schedule Finding Trial of AMG 531 for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Chemotherapy-Induced Thrombocytopenia;   Non-small Cell Lung Cancer;   Cancer;   Lung Neoplasms;   Oncology;   Solid Tumors;   Thrombocytopenia
Interventions: Biological: AMG 531 (romiplostim);   Drug: Placebo
32 Active, not recruiting Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention: Procedure: Exhaled Breath Sampling
33 Active, not recruiting Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
Conditions: Limited Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Tobacco Use Disorder
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Other: counseling intervention;   Other: internet-based intervention;   Behavioral: telephone-based intervention;   Other: educational intervention;   Drug: nicotine replacement therapy
34 Not yet recruiting Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Non-small-cell Lung Carcinoma;   Lung Cancer;   NSCLC
Interventions: Biological: gp96-Ig Vaccine;   Drug: Theophylline;   Other: Oxygen;   Procedure: Immunologic Evaluation
35 Recruiting Study of Arsenic Trioxide in Small Cell Lung Cancer
Conditions: Lung Cancer;   Cancer of Lung;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide
36 Completed Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: dasatinib
37 Recruiting Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Biological: cixutumumab;   Drug: paclitaxel;   Drug: carboplatin;   Biological: bevacizumab
38 Recruiting Azacitidine and MS-275 in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: entinostat;   Drug: azacitidine;   Other: pharmacological study
39 Recruiting Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Procedure: therapeutic lymphadenectomy;   Radiation: stereotactic body radiation therapy;   Procedure: quality-of-life assessment
40 Completed Lung Cancer Informational Study (LCIS)
Conditions: Cancer;   Enhanced Care;   Decision-Making;   Advance Lung Cancer;   Stage III Lung Cancer;   Stage IV Lung Cancer
Interventions: Behavioral: Enhance Care;   Behavioral: Usual Care
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years